|
Pulmatrix, Inc. (Pulm) Valation DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Pulmatrix, Inc. (PULM) Bundle
Vous cherchez à évaluer la valeur intrinsèque de Pulmatrix, Inc.? Notre calculatrice (Pulm) DCF intègre des données réelles avec des fonctionnalités de personnalisation complètes, vous permettant d'ajuster les prévisions et d'améliorer vos stratégies d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.9 | 12.6 | 5.2 | 6.1 | 7.3 | 8.0 | 8.8 | 9.6 | 10.5 | 11.5 |
| Revenue Growth, % | 0 | 59.72 | -59.09 | 17.45 | 20.21 | 9.57 | 9.57 | 9.57 | 9.57 | 9.57 |
| EBITDA | -13.2 | -9.9 | -15.4 | -17.4 | -13.3 | -7.6 | -8.4 | -9.2 | -10.1 | -11.0 |
| EBITDA, % | -167.41 | -78.06 | -297.04 | -286.64 | -181.76 | -95.61 | -95.61 | -95.61 | -95.61 | -95.61 |
| Depreciation | .8 | 1.0 | 1.2 | 1.5 | 1.5 | 1.4 | 1.5 | 1.7 | 1.8 | 2.0 |
| Depreciation, % | 9.67 | 8.26 | 23.91 | 25.45 | 20.21 | 17.5 | 17.5 | 17.5 | 17.5 | 17.5 |
| EBIT | -14.0 | -10.9 | -16.6 | -18.9 | -14.7 | -7.8 | -8.5 | -9.3 | -10.2 | -11.2 |
| EBIT, % | -177.08 | -86.31 | -320.95 | -312.09 | -201.97 | -97.26 | -97.26 | -97.26 | -97.26 | -97.26 |
| Total Cash | 23.4 | 31.7 | 53.8 | 35.6 | 19.2 | 8.0 | 8.8 | 9.6 | 10.5 | 11.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 7.2 | .1 | .1 | 1.3 | .9 | 2.0 | 2.2 | 2.4 | 2.7 | 2.9 |
| Account Receivables, % | 91.02 | 0.66487 | 1.3 | 21.38 | 12.72 | 25.42 | 25.42 | 25.42 | 25.42 | 25.42 |
| Inventories | .6 | .7 | .0 | .2 | .0 | .2 | .3 | .3 | .3 | .3 |
| Inventories, % | 7.03 | 5.28 | 0.000019346102 | 2.52 | 0 | 2.97 | 2.97 | 2.97 | 2.97 | 2.97 |
| Accounts Payable | .6 | .9 | .8 | 1.2 | 1.9 | 1.2 | 1.3 | 1.5 | 1.6 | 1.8 |
| Accounts Payable, % | 7.59 | 6.74 | 16.23 | 19.57 | 26.24 | 15.27 | 15.27 | 15.27 | 15.27 | 15.27 |
| Capital Expenditure | -.1 | -.3 | -.1 | -.1 | -.7 | -.3 | -.3 | -.3 | -.3 | -.4 |
| Capital Expenditure, % | -0.73325 | -2.22 | -2.79 | -1.42 | -9.26 | -3.28 | -3.28 | -3.28 | -3.28 | -3.28 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -13.9 | -16.1 | -18.5 | -18.8 | -14.7 | -7.8 | -8.5 | -9.3 | -10.2 | -11.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -20.3 | -8.1 | -16.7 | -18.4 | -12.7 | -8.7 | -7.4 | -8.1 | -8.8 | -9.7 |
| WACC, % | 9.87 | 9.88 | 9.88 | 9.88 | 9.88 | 9.88 | 9.88 | 9.88 | 9.88 | 9.88 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -32.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -10 | |||||||||
| Terminal Value | -125 | |||||||||
| Present Terminal Value | -78 | |||||||||
| Enterprise Value | -110 | |||||||||
| Net Debt | -10 | |||||||||
| Equity Value | -100 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | -27.34 |
What You Will Get
- Real PULM Financial Data: Pre-filled with Pulmatrix’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Pulmatrix’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Financial Inputs: Adjust essential metrics such as revenue projections, operating margins, and R&D expenses.
- Instant DCF Valuation: Quickly computes intrinsic value, net present value, and additional financial metrics.
- High-Precision Estimates: Leverages Pulmatrix's (PULM) actual financial data for accurate valuation results.
- Streamlined Scenario Analysis: Easily explore various assumptions and evaluate different outcomes.
- Efficiency Booster: Avoid the hassle of creating complex valuation models from the ground up.
How It Works
- Download the Template: Gain immediate access to the Excel-based PULM DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other parameters.
- Instant Calculations: The model automatically refreshes Pulmatrix's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the findings to inform your investment or financial strategy.
Why Choose This Calculator for Pulmatrix, Inc. (PULM)?
- Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and industry consultants.
- Accurate Data: Pulmatrix’s historical and projected financials are preloaded for precise calculations.
- Flexible Scenario Analysis: Easily simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance simplifies the entire process.
Who Should Use This Product?
- Investors: Evaluate Pulmatrix’s valuation before making stock transactions.
- CFOs and Financial Analysts: Optimize valuation workflows and assess financial forecasts.
- Startup Founders: Understand the valuation methods applied to biotech companies like Pulmatrix.
- Consultants: Provide detailed valuation reports for clients in the healthcare sector.
- Students and Educators: Utilize real-life data to practice and teach valuation strategies.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Pulmatrix, Inc. (PULM) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Pulmatrix, Inc. (PULM).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.